In women, pain symptoms and nociceptive thresholds vary with the reproductive cycle, suggesting the role of estrogen receptors (ERs) in modulating nociception. Our previous data strongly suggest an interaction between ERs and ATP-induced purinergic (P2X3) as well as ERs and capsaicin-induced vanilloid (TRPV1) receptors at the level of dorsal root ganglion (DRG) neurons. In this study, we investigated the expression of P2X3 and TRPV1 receptors by western blotting and immunohistochemistry in lumbosacral DRGs from wild type, ERa, and ERb knockout mice. We found a significant decrease for both P2X3 and TRPV1 in ERaKO and ERbKO. This phenomenon was visualized in L1, L2, L4, and L6 levels for P2X3 receptors and in L1, L2, and S2 levels for TRPV1 receptors. This tan interaction between P2X3/TRPV1 and ERs expression in sensory neurons may represent a novel mechanism that can explain the sex differences in nociception observed in clinical practice. The DRG is an important site of visceral afferent convergence and cross-sensitization and a potential target for designing new anti-nociceptive therapies. NeuroReport 23:530-534 c 2012 Wolters Kluwer Health | Lippincott
Introduction
The incidences of episodic or persistent visceral functional pain disorders such as irritable bowel syndrome, painful bladder syndrome, and fibromyalgia are much more prevalent in women than in men. Sensitization of primary afferent neurons may play a role in the enhanced perception of visceral sensation leading to pain. Several lines of evidence indicate that 17b-estradiol (E2) directly influences the functions of primary afferent neurons. Both subtypes of estrogen receptors (ERa and ERb) are present in dorsal root ganglion (DRG) neurons including the small-diameter putative nociceptors [1] . ATP-sensitive DRG neurons in primary culture respond to E2 [2, 3] . E2 modulates cellular activity by altering ion channel opening, G-protein signaling, and activation of trophic factor-like signal transduction pathways [4] . DRG neurons can be activated or modulated by the activation of chemosensitive receptors and ion channels on peripheral terminals. Once released into the intercellular areas, the action of ATP is mediated by purinergic receptors that are expressed on primary afferent fibers and cell bodies within DRG, suggesting a significant role for ATP release in neuropathic pain [5] . Although various types of P2X receptors are expressed in the DRG, the predominant ATP receptor is the P2X3 [6] .
The capsaicin-sensitive primary afferent neurons of smalldiameter and medium-diameter neurons mediate nociceptive-like behaviors, suggesting that TRPV1-expressing neurons are nociceptors. The activation of P2X3 and TRPV1 receptors results in the production of a cation current with a subsequent depolarization and opening of voltage-gated Ca 2+ channels and the sensation of pain is produced by depolarization of the peripheral nerve terminals [7] . Recently, we showed that E2 rapidly attenuates ATP-induced P2X3-mediated [Ca 2+ ] i signaling through membrane-associated ERa [3] . E2 may also play a key role in pain modulation by inhibiting the activation of transient receptor TRPV1 by capsaicin in nociceptor neurons [8] . The mechanism underlying the effect of E2 on the P2X3mediated and TRPV1-mediated nociceptive response needs further investigation and in this study we showed that the expression of both P2X3 and TRPV1 receptors was significantly reduced in estrogen receptor-a (ERaKO) and estrogen receptor-b (ERbKO) mice compared with the expression wild-type (Wt) mouse.
Materials and methods

Animals
We used 6-8-week-old female Wt (C57Bl/6J), ERaKO (B6.129P2-Esr1 tm1Ksk /J) and ERbKO (B6.129P2-Esr2 tm1Unc /J) mice (Jackson Laboratory, Bar Harbor, Maine, USA). Upon arrival, mice were housed in microisolator caging and maintained on a 12 h light/dark cycle in a temperature-controlled environment with access to food and water ad libitum for 2 weeks. All studies were carried out in accordance with the guidelines of the Institutional Animal Care and Use Committee of Charles R. Drew University and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. In some experiments, we used animals from our breeding colony.
Western blot analysis
The expressions of P2X3 and TRPV1 receptors in L1-S1 DRGs were studied using western blot analyses. Tissues from Wt (C57Bl/6J), ERaKO, and ERbKO mice were quick frozen in tubes on dry ice during collection. L1-S1 DRG were combined, homogenized by mechanical disruption on ice-cold RIPA buffer plus protease inhibitors, and incubated on ice for 30 min. Homogenates were then spun at 5000g for 15 min and the supernatants were collected. Total protein was determined on the supernatants using the bicinchoninic acid microtiter method (Pierce, Rockford, Illinois, USA). Samples containing equal amounts of protein (40 mg) were electrophoresed under denaturing conditions using the Novex Mini-cell system (San Diego, California, USA) and reagents (NuPage 4-12% Bis-Tris gel and MOPS running buffer). After electrophoretic transfer onto a nitrocellulose membrane using the same system, the membrane was blocked with 5% nonfat dry milk (NFDM) in 25 mmol/l Tris-buffered saline, pH 7.2, plus 0.1% Tween 20 (TBST) for 1 h at room temperature, followed by incubation with polyclonal rabbit antibody against P2X3 and the TRPV1 receptor (1 : 1000, Neuromics, Edina, Minnesota, USA) overnight at 41C. The membrane was then washed in TBST plus NFDM, and proteins were visualized using a horseradish peroxidaseconjugated secondary antibody (Santa Cruz Biotechnology, Santa Cruz, California, USA). Following a final wash in TBST without NFDM, the membrane was incubated with the ECL + (Amersham, Arlington Heights, Illinois, USA) substrate for horseradish peroxidase. Membranes were probed with the primary antibody and the corresponding secondary antibodies; signals were scanned and quantified by Image J version 1.28U and NIH Image 1.60 scan software (Research Service Branch, National Institute of Health, Bethesda, Maryland, USA). Following enhanced chemiluminescence detection of proteins, the membranes were stripped with stripping buffer (Pierce, Rockford, Illinois, USA) and rehybridized with b-actin antibody as a loading control. At least three independent cell preparations were used.
Immunohistochemistry
For tissue collection DRG from bilateral spinal levels L1-S1 were removed and fixed in 4% paraformaldehyde overnight at 41C. DRGs were rinsed in Delbecco's phosphate-buffered saline and kept in sucrose (20%, 41C) for cryoprotection (48 h), after which excess liquid was removed. Each DRG was mounted in Tissue-Tek OCT embedding medium (Sakura Finetek, Torrance, California, USA) and sectioned at -201C in a MICROM H505E (Viocompare, San Francisco, California, USA) cryostat. Sections were cut at 20 mm and collected in PBS. Endogenous tissue peroxidase activity was quenched by soaking the sections for 10 min in a 3% hydrogen peroxide solution in 0.01 mol/l PBS. The specimens were washed and then treated for 60 min in a blocking solution, 0.01 mol/l PBS containing 0.5% Triton X-100, and 1% normal donkey serum at room temperature. They were processed for Wt (n = 4), ERaKO (n = 4), or ERbKO (n = 4) immunohistochemistry by the free floating method using the polyclonal rabbit TRPV1 receptor antibody (1 : 50000, Neuromics) or the P2X3 receptor antibody (1 : 15000, Neuromics) overnight at 41C, washed in 0.01 mol/l PBS and 0.01 mol/l Tris-buffered saline, followed by incubation in solutions of donkey anti-rabbit fluorophore-conjugated secondary antibodies (1 : 200; Invitrogen, Carlsbad, California, USA) in 0.01 mol/l Trisbuffered saline for 3 h at room temperature. Cells that showed no apparent or only faint membrane/intracellular labeling were considered to be negative for TRPV1 or P2X3. P2X3-positive neurons showed diffuse membrane/ intracellular labeling. Mounted sections were air dried and coverslipped with Aqua Poly Mount (Polisciences, Warrington, Pennsylvania, USA). TRPV1-positive cells included those with strong plasma membrane labeling that formed a discernible clustered pattern and those with strong intracellular labeling that formed a punctuate pattern. Some neurons showed both strong plasma membrane and intracellular labeling. Images from at least three sections in each level were taken using a Leica DMLB M130X microscope (Buffalo Grove, Illinois, USA). The total numbers of DRG neurons expressing TRPV1 and P2X3 were counted. TRPV1/P2X3-positive neurons were categorized according to their labeling patterns and were expressed as a percentage of the total number of TRPV1/P2X3-positive cells. Immunohistochemical signal percent was measured by computerized image analysis (Image Pro-Plus, Media Cybernetics, Silver Spring, Maryland, USA).
Statistical analysis
The amplitude of the [Ca 2+ ] i response represents the difference between the baseline concentration and the transient peak response to drug stimulation. Significant differences in response to chemical stimulation were obtained by comparing increases in [Ca 2+ ] i during the first stimulation with the second. All of the data are expressed as the mean ± SEM. Statistical analysis was performed using the Statistical Package for the Social Sciences 15.0 (SPSS Inc., Chicago, Illinois, USA). To assess the significance among different groups, data were analyzed by one-way analysis of variance, followed by the Schéffe post-hoc test. A P less than 0.05 was considered statistically significant.
Results
Expression of P2X3 and TRPV1 receptors in whole-cell lysates in DRG neurons from Wt, ERaKO, and ERbKO mice
The expression of P2X3 and TRPV1 receptors was examined by western blot analysis of lysates from Wt, ERaKO, and ERbKO DRG tissues using a P2X3 specific primary antiserum (Fig. 1a ). Intense bands representing an B64 kDa protein (P2X3) and an B130 kDa (TRPV1) were seen in DRG lysates from Wt animals. There was a marked decrease in the intensity of these bands using lysates made from both the ERaKO and ERbKO knockout DRG tissues compared with Wt animals (> 4-fold decrease Fig. 1a) . A representative result of P2X3/TRPV1 receptors and the standardization ratio statistics are shown in Fig. 1b . The average intensities of the bands in both knockout mice decreased significantly. When the density in the control group was standardized to 1.0, the average densities were 0.172 ± 0.08 for ERaKO and 0.262 ± 0.10 for ERbKO in P2X3 receptors and 0.59 ± 0.06 in ERaKO and 0.391 ± 0.04 in ERbKO for TRPV1 receptors (n = 4, P < 0.05). Our data strongly suggest that both P2X3 and TRPV1 protein decreased in DRG from ERs knockout mice.
Distribution of P2X3 and TRPV1 receptors in L1-S1 levels of DRG neurons from WT, ERaKO, and ERbKO mice
Nociceptive capsaicin-sensitive ATP-sensitive P2X3 receptors and capsaicin-sensitive TRPV1 receptors are expressed in lumbosacral small DRG neurons. DRGs from each level (L1-S1) were immunostained with primary antibodies against P2X3 and TRPV1. Neuronal profiles from ERaKO, ERbKO as well as Wt mice (n = 4 in each group) were quantified for different fluorescent probes. Both nociceptive-mediating P2X3 and TRPV1 receptors were present in DRG neurons (Figs 2a and 3a) . The distributions of labeled DRG neurons showed a statistically significant difference between L1, L2, L4, and L6 levels of P2X3 receptors and L1, L2, and S1 levels of TRPV1 receptors in both ERaKO and ERbKO DRG neurons in comparison with Wt mice. There was also a statistically significant difference in the L5 level of P2X3 and L3 and L4 of TRPV1 in Wt compared with ERaKO (Figs 2b and 3b; P < 0.05, n = 4 in each group).
Discussion
The incidence of persistent, episodic, or chronic visceral pain is more prevalent in women, thus defining the site(s) and mechanism through which female steroid hormones modulate pain is an important step in understanding the sex differences in pain perception.
In previous studies, we showed that E2 acts through an ERa in modulating the ATP/capsaicin-mediated [Ca 2 + ] i response in DRG, as its effect was eliminated in ERaKO mouse and retained in ERbKO ( [3] and T. Cho and V. Chaban, unpublished observations). In this study, we found a correlation between the expression of P2X3/TRPV1 and ERa/ERb. The expression of P2X3 receptors was significantly decreased in L1, L2, L4, and L6 levels and the expression of TRPV1 receptors in L1, L2, S1 levels in both ERaKO and ERbKO mice.
Elucidating the mechanisms through which E2 modulates nociception is an important step in designing appropriate therapies for the treatment of pain. This study supports the potential of the P2X3 and TRPV1 receptor as a pain therapy target in women. ATP released by noxious stimulation and tissue damage has been found near the peripheral terminal of primary sensory afferent neurons [9] . Evidence for TRPV1's role in their pathogenesis comes from studies showing that mice lacking the TRP1 receptor gene have deficits in thermal-induced or inflammatory-induced hyperalgesia [10] . Although large numbers of clinical and animal studies have indicated that there are sex and estrous cycle differences in the pain perception of various pain models [11] , it remains unclear whether this occurs in capsaicin-induced pain response.
The activation of both capsaicin-sensitive TRPV1 and ATP-sensitive P2X3 receptors caused desensitization correlating to the antinociception. Therefore, we hypothesized that changes in the capsaicin-sensitive TRPV1 receptor may show a level of DRG neuron activation by noxious cutaneous stimuli, but changes in the ATP-sensitive P2X3 receptor in [Ca 2+ ] i may affect the level of DRG neuron sensitization by noxious visceral stimulation [12] . The effects of E2 on visceral nociceptive signaling have been observed in clinical studies, but most of the research has been focused on the central nervous system. This study, however, was focused on the nociceptive signaling mechanisms in the peripheral nervous system, at the level of DRG, and how ERs modulate encoding of nociceptive stimuli that may contribute to the development of cure for many functional pain-associated syndromes.
